SCHEMBL6162697

SCHEMBL6162697

O=C1N=CN(c2ccccc2)C12CCNCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.50
TSHR P16473 5/20 0.42
USP2 O75604 8/20 0.41
CYP2D6 P10635 7/20 0.41
ALDH1A1 P00352 6/20 0.38
CYP3A4 P08684 5/20 0.38
CYP2C19 P33261 4/20 0.38
SIGMAR1 Q99720 3/20 0.37
OPRM1 P35372 1/20 0.37
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
ADRB1 P08588 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
CYP1A2 P05177 5/20 0.36
TP53 P04637 4/20 0.36
MAPK1 P28482 3/20 0.36
HIF1A Q16665 2/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16876839 0.85 HSD17B10 (0.35) HSD17B10TSHRUSP2ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL8808669 0.84 HSD17B10 (0.35) HSD17B10TSHRUSP2ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL7841330 0.82 ADRB1 (0.44) HSD17B10OPRM1ADRB1MAPT
SCHEMBL16876824 0.79 CYP11B2 (0.34) HSD17B10TSHRSIGMAR1DRD2
SCHEMBL7706497 0.76 OPRL1 (0.54) HSD17B10TSHRALDH1A1CYP3A4CYP2C19
SCHEMBL16876890 0.76 ADRB1 (0.33) HSD17B10ADRB1
SCHEMBL15759065 0.74 SIGMAR1 (0.50) TSHRCYP2D6SIGMAR1OPRM1DRD2
SCHEMBL4355371 0.72 HSD17B10 (0.57) HSD17B10TSHRUSP2CYP2D6ALDH1A1
SCHEMBL16876780 0.72 OPRM1 (0.34) OPRM1TP53LMNA
SCHEMBL5555955 0.70 SLC6A9 (0.59) OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997464-B1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists PFIZER (US) 2005-02-16 EP disclosed
US-6465478-B1 1,3,8-Triuazaspiro(4,5)decanone compounds as ORL1-receptor agonists PFIZER INC. 2002-10-15 US disclosed
EP-0997464-A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists PFIZER INC. (US) 2000-05-03 EP disclosed
WO-2000023444-A1 5,7-DISUBSTITUTED-4-AMINOPYRIDO[2,3-D]PYRIMIDINE COMPOUNDS ABBOTT LABORATORIES (US) 2000-04-27 WO disclosed
EP-0696280-B1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL PHARMA INC (US) 1997-09-24 EP disclosed
US-5661160-A ADMINISTERING AN ANTITUSSIVE AGENT FOR TREATING COUGH; TACHYKININ ANTAGONISM, SUBSTANCE P AND NEUROKININ A ANTAGONISM MERRELL PHARMACEUTICALS INC. (US) 1997-08-26 US disclosed
US-5648366-A TACHYKININ ANTAGONISTS USEFUL IN TREATING ASTHMA MERRELL PHARMACEUTICALS INC. (US) 1997-07-15 US disclosed
US-5635510-A TACHYKININ (ESPECIALLY SUBSTANCE P AND NEUROKININ A) ANTAGONISTS; ANTIINFLAMMATORY AGENTS, ANALGESICS; NERVOUS SYSTEM DISORDERS; BRONCHODILATOR AGENTS MERRELL PHARMACEUTICALS INC. (US) 1997-06-03 US disclosed
EP-0696280-A1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL DOW PHARMA (US) 1996-02-14 EP disclosed
WO-1994026735-A1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL DOW PHARMACEUTICALS INC. (US) 1994-11-24 WO disclosed